Name
PD13-04 - Activity of patritumab deruxtecan, a HER3-directed antibody drug conjugate, in early breast cancer according to ERBB3 expression: interim analysis results of a window of opportunity study (SOLTI-1805 TOT-HER3)
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link